CMPX
Compass Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C
Company Profile
CEO
Thomas J. Schuetz
IPO Date
2021-04-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Compass Therapeutics, Inc.
CEO
Thomas J. Schuetz
IPO Date
2021-04-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 25,000 |
| $1.89 |
| 29 Apr 2026 | Anderman Jonathan | General Counsel | A-Award | Acquired | 25,000 | $1.89 |
| 29 Apr 2026 | Lerner Neil | Chief Accounting Officer | A-Award | Acquired | 15,000 | $1.89 |
| 10 Feb 2026 | Schuetz Thomas J. | director, officer: CHIEF EXECUTIVE OFFICER | F-InKind | Disposed | 36,687 | $6.52 |
| 12 Jan 2026 | Schuetz Thomas J. | director, officer: CHIEF EXECUTIVE OFFICER | F-InKind | Disposed | 46,777 | $5.35 |
| 5 Jan 2026 | Shin Barry | CFO | A-Award | Acquired | 125,000 | $5.17 |
| 5 Jan 2026 | Shin Barry | CFO | A-Award | Acquired | 670,000 | $5.17 |
| 5 Jan 2026 | Sirard Cynthia | Chief Medical Officer | A-Award | Acquired | 1,000,000 | $5.17 |
| 5 Jan 2026 | Schuetz Thomas J. | director, officer: CEO | A-Award | Acquired | 250,000 | $5.17 |